BACKGROUND: The role of β-glucan in children with respiratory problems is getting more and more attention. In this report we focused on the effects of 30 days oral supplementation with β-glucan on physical activity and immune status of children with respiratory problems. METHODS: We measured the level of sIgA, eNO and physical activity [using a 6-minute walking test (6MWT)] in 77 children and evaluated the effect of 100 mg/day oral dose. RESULTS: We found a significant difference between males and females in physical endurance. In the glucan group, the positive effects of glucan were significant in both age groups. In the glucan group, we found significant decrease of eNO levels and stabilization of the sIgA levels. CONCLUSIONS: Short-term oral application of natural immunomodulator β-glucan stimulated physical endurance in children with respiratory problems and, via stabilization of the sIgA levels, helps their mucosal immunity.
BACKGROUND: The role of β-glucan in children with respiratory problems is getting more and more attention. In this report we focused on the effects of 30 days oral supplementation with β-glucan on physical activity and immune status of children with respiratory problems. METHODS: We measured the level of sIgA, eNO and physical activity [using a 6-minute walking test (6MWT)] in 77 children and evaluated the effect of 100 mg/day oral dose. RESULTS: We found a significant difference between males and females in physical endurance. In the glucan group, the positive effects of glucan were significant in both age groups. In the glucan group, we found significant decrease of eNO levels and stabilization of the sIgA levels. CONCLUSIONS: Short-term oral application of natural immunomodulator β-glucan stimulated physical endurance in children with respiratory problems and, via stabilization of the sIgA levels, helps their mucosal immunity.
Authors: C Casanova; B R Celli; P Barria; A Casas; C Cote; J P de Torres; J Jardim; M V Lopez; J M Marin; M Montes de Oca; V Pinto-Plata; A Aguirre-Jaime Journal: Eur Respir J Date: 2010-06-04 Impact factor: 16.671
Authors: Ralf Geiger; Julia Willeit; Meike Rummel; Wolfgang Högler; Kurt Stübing; Alexander Strasak; Harald Geiger; Joerg I Stein; Markus Rauchenzauner Journal: J Pediatr Date: 2011-03 Impact factor: 4.406
Authors: Milos Jesenak; Juraj Majtan; Zuzana Rennerova; Jan Kyselovic; Peter Banovcin; Martin Hrubisko Journal: Int Immunopharmacol Date: 2012-12-20 Impact factor: 4.932
Authors: Anna Bzducha-Wróbel; Katarzyna Pobiega; Stanisław Błażejak; Marek Kieliszek Journal: Appl Microbiol Biotechnol Date: 2018-09-13 Impact factor: 4.813